Study of Radiotherapy and Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Patients Previously Treated with Radiation
A Multi-Center Observational Study by the Italian Association for Radiotherapy and Clinical Oncology
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2023-08-09
88
Participants Needed
1
Research Sites
260 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying recurrent rectal cancer in patients who have already received radiation therapy to the pelvic area. The study focuses on evaluating different types of radiotherapy, including reirradiation, and chemotherapy intensification to improve outcomes after local recurrence. This research aims to understand how combining surgery, chemotherapy, and advanced radiotherapy techniques can better control the cancer while considering previous treatments and patient condition.
The study observes patients receiving reirradiation treatments using modern methods like volumetric modulated arc therapy VMAT, stereotactic body radiotherapy SBRT, proton therapy, and carbon ion radiotherapy. Total Neoadjuvant Therapy, which involves chemotherapy before surgery, is also considered. The study is observational and multi-center, allowing careful stratification to select appropriate therapies based on the recurrence type and clinical status.
Participants will be monitored for their response to treatment and local cancer control over an eight-year period. Researchers will collect clinical data, imaging, and treatment details, ensuring participants meet specific health and functional criteria. The study will assess outcomes such as local control of the cancer and monitor safety and compliance throughout the follow-up, which may extend up to eight years after treatment.
CONDITIONS
Brief Title
Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Liver enzymes (ALT/AST) within 7-45 international units per liter
Potentially curable oligo-metastatic disease
Life expectancy greater than 24 months
Pelvic local recurrent rectal cancer confirmed by histology if possible, or by MRI, CT, and/or PET scans
Previous pelvic irradiation completed more than 6 months ago
Availability of previous treatment plan in DICOM format
You will not qualify if you...
Age under 18 years
Pregnant or breastfeeding women
Psychological, family, social, or geographic conditions that may prevent following the study or follow-up
Significant health problems such as severe heart or blood clotting disorders, moderate to severe lung problems, severe cognitive impairment, or moderate to severe kidney or liver dysfunction
Refusal to sign informed consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Duration of reirradiation as per clinical indication
Participants undergo reirradiation for recurrent rectal cancer.
Visits scheduled according to treatment plan
Long-term Monitoring
Duration - Up to 8 years
Participants are monitored for local control and overall health following treatment.
Follow-up visits according to clinical practice
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Comparing Stapled and Hand-sewn Methods for Closing Loop Ileostomy After Rectal Cancer Surgery and Studying Mesh Versus Suture for Stoma Site Closure
Study of Radiotherapy and Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Patients Previously Treated with Radiation
A Multi-Center Observational Study by the Italian Association for Radiotherapy and Clinical Oncology
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study.
Maria Antonietta Gambacorta, Angela Romano, Luciana Caravatta...